Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fatimah Sherbeny

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cutis|May 29, 2020
Smartphones: dermatologic impact of the digital ageChristopher Mancuso, Lauren Dozier, Fatimah Sherbeny, et al.
Innovations in Pharmacy|January 19, 2023
Exploratory Analysis of Survival and Mortality Rates among Older Lung Cancer Patients Utilizing Different Treatment ModalitiesAbdulmajeed Alotaibi, Askal Ali, Clyde Brown, et al.
Journal of the American Pharmacists Association : Japha|September 24, 2023
Impact of a centralized population health pharmacy program on value-based Medicare patientsDovena Lazaridis, Dor Partosh, Lazara Cabrera Ricabal, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|May 25, 2023
Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC/AHA guidelinesAmro Matyori, Clyde P Brown, Askal Ali, et al.
Clinical Drug Investigation|May 25, 2022
Cost Effectiveness of Dapagliflozin Added to Standard of Care for the Management of Diabetic Nephropathy in the USATadesse M Abegaz, Vakaramoko Diaby, Fatimah Sherbeny, et al.
Transplantation Proceedings|October 23, 2023
Deep Learning-Based Survival Analysis for Receiving a Steatotic Donor Liver Versus Waiting for a Standard LiverXiao Zhang, Matthew Dutton, Rongjie Liu, et al.
Computers in Biology and Medicine|August 9, 2023
Machine learning algorithms to predict major adverse cardiovascular events in patients with diabetesTadesse M Abegaz, Ahmead Baljoon, Oluwaseun Kilanko, et al.
Journal of Managed Care & Specialty Pharmacy|September 26, 2025
A systematic review of the applications of the real option value of medical technologies in oncologyKwame Adjei, Vakaramoko Diaby, Meng Li, et al.
Clinical Drug Investigation|May 29, 2026
Estimating the Real Option Value of Osimertinib Compared to Standard EGFR-TKI in the Treatment of Advanced NSCLC in the United StatesKwame Adjei, Vakaramoko Diaby, Meng Li, et al.
Healthcare (Basel, Switzerland)|April 28, 2023
Application of Machine Learning Algorithms to Predict Uncontrolled Diabetes Using the All of Us Research Program DataTadesse M Abegaz, Muktar Ahmed, Fatimah Sherbeny, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cutis|May 29, 2020
Smartphones: dermatologic impact of the digital ageChristopher Mancuso, Lauren Dozier, Fatimah Sherbeny, et al.
Innovations in Pharmacy|January 19, 2023
Exploratory Analysis of Survival and Mortality Rates among Older Lung Cancer Patients Utilizing Different Treatment ModalitiesAbdulmajeed Alotaibi, Askal Ali, Clyde Brown, et al.
Journal of the American Pharmacists Association : Japha|September 24, 2023
Impact of a centralized population health pharmacy program on value-based Medicare patientsDovena Lazaridis, Dor Partosh, Lazara Cabrera Ricabal, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|May 25, 2023
Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC/AHA guidelinesAmro Matyori, Clyde P Brown, Askal Ali, et al.
Clinical Drug Investigation|May 25, 2022
Cost Effectiveness of Dapagliflozin Added to Standard of Care for the Management of Diabetic Nephropathy in the USATadesse M Abegaz, Vakaramoko Diaby, Fatimah Sherbeny, et al.
Transplantation Proceedings|October 23, 2023
Deep Learning-Based Survival Analysis for Receiving a Steatotic Donor Liver Versus Waiting for a Standard LiverXiao Zhang, Matthew Dutton, Rongjie Liu, et al.
Computers in Biology and Medicine|August 9, 2023
Machine learning algorithms to predict major adverse cardiovascular events in patients with diabetesTadesse M Abegaz, Ahmead Baljoon, Oluwaseun Kilanko, et al.
Journal of Managed Care & Specialty Pharmacy|September 26, 2025
A systematic review of the applications of the real option value of medical technologies in oncologyKwame Adjei, Vakaramoko Diaby, Meng Li, et al.
Clinical Drug Investigation|May 29, 2026
Estimating the Real Option Value of Osimertinib Compared to Standard EGFR-TKI in the Treatment of Advanced NSCLC in the United StatesKwame Adjei, Vakaramoko Diaby, Meng Li, et al.
Healthcare (Basel, Switzerland)|April 28, 2023
Application of Machine Learning Algorithms to Predict Uncontrolled Diabetes Using the All of Us Research Program DataTadesse M Abegaz, Muktar Ahmed, Fatimah Sherbeny, et al.
Pageof 2